Skip to main content
HeartCited

Vitamin K2
Vitamin K2

vitamin

别名: Menaquinone, MK-7, MK-4, Menaquinone-7, Menaquinone-4

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dvitamin\u002Dk2'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

About

Vitamin K2 activates matrix Gla protein (MGP), the most potent natural inhibitor of arterial calcification, directing calcium to bones and away from arteries. The Rotterdam Heart Study (4,807 participants) found the highest vitamin K2 intake was associated with 57% reduction in cardiovascular mortality and 52% reduction in severe aortic calcification.

How It Works

Activates matrix Gla protein (MGP) — the most potent natural inhibitor of arterial calcification — through gamma-carboxylation; directs calcium deposition to bones and away from arteries by activating osteocalcin (bone) and MGP (arteries); the MK-7 form has the longest half-life (72 hours) providing sustained vascular protection; works synergistically with vitamin D.

Evidence For Conditions

健康状况 等级 研究数量 受试者
Arterial Stiffness B 5 1200 查看 →

Side Effects

  • Generally very well-tolerated
  • Does not affect blood clotting (INR) at supplemental doses, unlike K1

Drug & Supplement Interactions

  • Warfarin (patients on warfarin should consult physician before K2 supplementation)
  • Vitamin D (synergistic — D increases MGP production, K2 activates it)

请务必告知您的医疗保健提供者您正在服用的所有补充剂。

Related Ingredients

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。